TJP1 and hepatocellular carcinoma: Wang et al. found that miR-122 can inhibit the invasion and metastasis of hepatocellular carcinoma through the RhoA pathway and that the mechanism involves specific binding of miR-122 to the mRNA sequence of RhoA, [67] inhibiting RhoA activity and F-actin and increasing expression of ZO-1.